Dr. Mark Russell Brown, DO General Practice Medicare: Not Enrolled in Medicare Practice Location: 3551 Roger Brooke Dr, Jbsa Ft Sam Houston, TX 78234 Phone: 210-292-7805 Fax: 210-292-7868 |
Dr. Kimera Amanda Joseph, MD General Practice Medicare: Medicare Enrolled Practice Location: 3551 Roger Brooke Dr, Pediatric Residency Program, Jbsa Ft Sam Houston, TX 78234 Phone: 210-916-9928 Fax: 210-916-9332 |
Dr. Benjamin Samuel Prewitt, DO General Practice Medicare: Medicare Enrolled Practice Location: 3551 Roger Brooke Dr, Jbsa Ft Sam Houston, TX 78234 Phone: 210-292-5077 Fax: 210-916-2077 |
Manuela Gaviria, MD General Practice Medicare: Not Enrolled in Medicare Practice Location: 3551 Roger Brooke Dr, Jbsa Ft Sam Houston, TX 78234 Phone: 210-916-1284 |
News Archive
Sosei Group Corporation announce the commencement of the Phase III clinical programme by Novartis, with QVA149, a once-daily, dry powder bronchodilator for inhalation combining a fixed dose of the once-daily beta2-agonist QAB149 (indacaterol) and the long-acting muscarinic antagonist NVA237 (glycopyrronium bromide) for the treatment of chronic obstructive pulmonary disease (COPD). The start of Phase III triggers a $7.5m milestone payment to Sosei.
Drugs commonly prescribed to treat Parkinson's disease have been linked to impulse control disorders such as pathological gambling, compulsive buying, hypersexuality and binge eating in some patients, report neurologists from Loyola Medicine and Loyola University Chicago Stritch School of Medicine.
TapImmune Inc. announced that it has signed an exclusive Licensing Option agreement with Mayo Clinic, Rochester, MN, for clinical development of a breast cancer vaccine technology. The option to license this technology can be exercised after Phase I clinical trials under terms agreed between Mayo Clinic and TapImmune.
For years, scientists have been puzzled by the presence of short stretches of genetic material floating inside a variety of cells, ranging from bacteria to mammals, including humans. These fragments are pieces of the genetic instructions cells use to make proteins, but are too short a length to serve their usual purpose.
Abt Associates announced today the sale of its wholly-owned subsidiary Abt Bio-Pharma Solutions, Inc. to United BioSource Corporation, a global scientific and medical affairs organization that partners with life science companies to develop and commercialize biopharmaceuticals, medical devices, and other health care technologies.
› Verified 2 days ago